Bicara Therapeutics' Insider Activity and Recent Clinical Updates Under Scrutiny
Executive activity at Bicara Therapeutics Inc. (NASDAQ:BCAX) shows a mixed picture with recent sales of common stock by the President and COO, counterbalanced by option acquisitions. The company recently reported first-quarter 2026 financial results, which included an earnings per share (EPS) miss, but also highlighted strong cash reserves and cont…